Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease

BACKGROUND: Scleroderma (SSc) patients with active interstitial lung disease (ILD) experience a decline in lung function and increased mortality; cyclophosphamide (CYC) therapy may stabilize lung function at one and two years follow-up. Long-term lung function and survival outcomes of SSc patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittoo, S, Wigley, Fredrick M, Wise, Robert A, Woods, Adrianne, Xiao, Huiqing, Hummers, Laura K
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087310/
https://www.ncbi.nlm.nih.gov/pubmed/21552414
http://dx.doi.org/10.2174/1874312901105010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087310/
https://www.ncbi.nlm.nih.gov/pubmed/21552414
http://dx.doi.org/10.2174/1874312901105010001

Ejemplares similares